Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study

Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study Cases of complete remission of cancers with brain metastases are very rare. It’s often brought by tyrosine kinase inhibitor monotherapy in patients with metastatic renal cell carcinoma. For metastatic renal cell carcinoma (mRCC) patients, the case of brain metastasis has been

Renal Cell Carcinoma- Prognosis via Albumin Levels

Renal Cell Carcinoma- Prognosis via Albumin Levels Metastatic renal cell carcinoma (mRCC) - An Introduction Renal cell carcinoma (RCC) constitutes approximately 90% of all urologic malignancies. Approximately 30% of patients with RCC present with metastatic disease, and amongst those with localized disease, a substantial proportion will recur. Before 2005, immunotherapy with interleukin-2

Remission of Renal Cell Carcinoma With Brain Metastases: A Case Study